Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Bone pain, Cold sweat, Computerised tomogram, Decreased interest
Clinical narrative: bone pain; sore arm, body ache; blurred vision; insomnia; restlessness; mild depression a feeling of not wanting to do anything; loss of will; night sweats; clammy hands; fatigue; headache; 45 days after second shot still having side effects.; Foggy feeling in head; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (45 days after second shot still having side effects.), FEELING ABNORMAL (Foggy feeling in head), BONE PAIN (bone pain), MYALGIA (sore arm, body ache) and VISION BLURRED (blurred vision) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046b21a and 006b21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included METOPROLOL TARTRATE from 2015 to an unknown date for Blood pressure raised, ATORVASTATIN from 02-Jan-2021 to an unknown date for Cholesterol, ALLOPURINOL from 2018 to an unknown date for Gout, TAMSULOSIN from 2019 to an unknown date for Renal disorder NOS, LEVOTHYROXINE from 2018 to an unknown date for Thyroid disorder.   On 24-Mar-2021 at 1:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced FEELING ABNORMAL (Foggy feeling in head). On an unknown date, the patient experienced VACCINATION COMPLICATION (45 days after second shot still having side effects.), BONE PAIN (bone pain), MYALGIA (sore arm, body ache), VISION BLURRED (blurred vision), INSOMNIA (insomnia), RESTLESSNESS (restlessness), DEPRESSION (mild depression a feeling of not wanting to do anything), DECREASED INTEREST (loss of will), NIGHT SWEATS (night sweats), COLD SWEAT (clammy hands), FATIGUE (fatigue) and HEADACHE (headache). The patient was treated with ACETYLSALICYLIC ACID (ASPRIN) on 05-May-2021 for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (45 days after second shot still having side effects.) outcome was unknown and FEELING ABNORMAL (Foggy feeling in head), BONE PAIN (bone pain), MYALGIA (sore arm, body ache), VISION BLURRED (blurred vision), INSOMNIA (insomnia), RESTLESSNESS (restlessness), DEPRESSION (mild depression a feeling of not wanting to do anything), DECREASED INTEREST (loss of will), NIGHT SWEATS (night sweats), COLD SWEAT (clammy hands), FATIGUE (fatigue) and HEADACHE (headache) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: normal (normal) normal. On an unknown date, Computerised tomogram: normal (normal) Normal. On an unknown date, Electrocardiogram: normal (normal) Normal. On an unknown date, Urine analysis: normal (normal) normal.         Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Follow up received: Contain No new information On 23-Jul-2021: Reporter details, Patient demographics, race and ethnicity were updated. product dose information was added. Concomitant and treatment  medication were added. New adverse events and Events outcome was updated.